Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Cox

Showing results (221-230 of 244) with videos related to

Pageof 25
Sort By:
American Journal of Clinical Oncology|April 16, 1998
SK&F107647: a synthetic hematoregulatory peptide in patients with solid tumor malignancies: a phase I trialJ Nemunaitis, D E Martin, D L Willis, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|October 28, 2018
QTc and anti-tuberculosis drugs: a perfect storm or a tempest in a teacup? Review of evidence and a risk assessmentI Monedero-Recuero, L Hernando-Marrupe, A Sánchez-Montalvá, et al.
JCO Oncology Practice|July 13, 2021
Oncology Medical Home: ASCO and COA StandardsKim Woofter, Erin B Kennedy, Kerin Adelson, et al.
Clinical Obesity|March 16, 2022
Effects of fitness and fatness on age-related arterial stiffening in people with type 2 diabetesEmily R Cox, Wendy J Brown, Trishan Gajanand, et al.
Neurogastroenterology and Motility|December 13, 2005
Barostat testing of rectal sensation and compliance in humans: comparison of results across two centres and overall reproducibilityF Cremonini, L A Houghton, M Camilleri, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|October 18, 2017
The devil we know: is the use of injectable agents for the treatment of MDR-TB justified?A Reuter, P Tisile, D von Delft, et al.
Neurogastroenterology and Motility|August 31, 2007
Effect of the NK(3) receptor antagonist, talnetant, on rectal sensory function and compliance in healthy humansL A Houghton, F Cremonini, M Camilleri, et al.
The New England Journal of Medicine|September 28, 2000
Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study GroupL B Saltz, J V Cox, C Blanke, et al.
Circulation Research|February 27, 2007
Alternative splicing of ryanodine receptors modulates cardiomyocyte Ca2+ signaling and susceptibility to apoptosisChristopher H George, Sarah A Rogers, Benedicte M A Bertrand, et al.
Stem Cells (Dayton, Ohio)|February 12, 2016
Junctional Adhesion Molecule-A Is Highly Expressed on Human Hematopoietic Repopulating Cells and Associates with the Key Hematopoietic Chemokine Receptor CXCR4Chao-Hui Chang, Sarah J Hale, Charlotte V Cox, et al.
Pageof 25

Showing results (221-230 of 244) with videos related to

Sort By:
Pageof 25
American Journal of Clinical Oncology|April 16, 1998
SK&F107647: a synthetic hematoregulatory peptide in patients with solid tumor malignancies: a phase I trialJ Nemunaitis, D E Martin, D L Willis, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|October 28, 2018
QTc and anti-tuberculosis drugs: a perfect storm or a tempest in a teacup? Review of evidence and a risk assessmentI Monedero-Recuero, L Hernando-Marrupe, A Sánchez-Montalvá, et al.
JCO Oncology Practice|July 13, 2021
Oncology Medical Home: ASCO and COA StandardsKim Woofter, Erin B Kennedy, Kerin Adelson, et al.
Clinical Obesity|March 16, 2022
Effects of fitness and fatness on age-related arterial stiffening in people with type 2 diabetesEmily R Cox, Wendy J Brown, Trishan Gajanand, et al.
Neurogastroenterology and Motility|December 13, 2005
Barostat testing of rectal sensation and compliance in humans: comparison of results across two centres and overall reproducibilityF Cremonini, L A Houghton, M Camilleri, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|October 18, 2017
The devil we know: is the use of injectable agents for the treatment of MDR-TB justified?A Reuter, P Tisile, D von Delft, et al.
Neurogastroenterology and Motility|August 31, 2007
Effect of the NK(3) receptor antagonist, talnetant, on rectal sensory function and compliance in healthy humansL A Houghton, F Cremonini, M Camilleri, et al.
The New England Journal of Medicine|September 28, 2000
Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study GroupL B Saltz, J V Cox, C Blanke, et al.
Circulation Research|February 27, 2007
Alternative splicing of ryanodine receptors modulates cardiomyocyte Ca2+ signaling and susceptibility to apoptosisChristopher H George, Sarah A Rogers, Benedicte M A Bertrand, et al.
Stem Cells (Dayton, Ohio)|February 12, 2016
Junctional Adhesion Molecule-A Is Highly Expressed on Human Hematopoietic Repopulating Cells and Associates with the Key Hematopoietic Chemokine Receptor CXCR4Chao-Hui Chang, Sarah J Hale, Charlotte V Cox, et al.
Pageof 25